SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[NEWS RELEASE Skystar Bio-Pharmaceutical Reports First Quarter 2011 Results $7.0 Million Top Line; $0.27 Diluted EPS; Reiterates Fiscal 2011 Top Line Guidance range of $60 Million to $63 Million “ ” “ ” XI’AN, CHINA – May 23, 2011 -- Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ( First Quarter 2011 Highlights · Revenue increases 46% YoY to $7.0 million · Veterinary vaccines]

By | 2016-03-01T05:18:01+00:00 May 24th, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: NEWS RELEASE Skystar Bio-Pharmaceutical Reports First Quarter 2011

[NEWS RELEASE Skystar Bio-Pharmaceutical Reports First Quarter 2011 Results $7.0 Million Top Line; $0.27 Diluted EPS; Reiterates Fiscal 2011 Top Line Guidance range of $60 Million to $63 Million “ ” “ ” XI’AN, CHINA – May 23, 2011 -- Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ( First Quarter 2011 Highlights · Revenue increases 46% YoY to $7.0 million · Veterinary vaccines]

By | 2016-03-01T05:18:40+00:00 May 24th, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

CTC [IFM Investments] 20-F: FORM 20-F (Mark One) o OR ý For

[FORM 20-F (Mark One) o OR ý For the fiscal year ended December 31, 2010. OR o For the transition period from to . OR o Date of event requiring this shell company report. IFM Investments Limited N/A Cayman Islands (Jurisdiction of incorporation or organization) 26/A, East Wing Donald Zhang Title of Each Class Name of each exchange on which] [Wholly-owned subsidiaries : · IFM Company Ltd., incorporated in the Cayman Islands · Beijing Aifeite International Franchise Consultant Co., Ltd., incorporated in the People’s Republic of China · City Integrated Residential Services (China) Limited, incorporated in Hong Kong, S.A.R. · Shanghai Yaye Real Estate Brokerage Co., Ltd., incorporated in the People’s Republic of China · CIR Real Estate Consultant (Shenzhen)] [Certification by the Chief Executive Officer I, Donald Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of IFM Investments Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [Certification by the Chief Financial Officer I, Kevin Cheng Wei, certify that: 1. I have reviewed this annual report on Form 20-F of IFM Investments Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [Certification by the Chief Executive Officer (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Donald Zhang Chief Executive Officer EX-13.1 5 a2204293zex-13_1.htm EX-13.1] [Certification by the Chief Financial Officer (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Kevin Cheng Wei Chief Financial Officer EX-13.2 6 a2204293zex-13_2.htm EX-13.2] [Consent of Commerce & Finance Law offices, PRC Counsel IFM Investments Limited 26/A, East Wing, Hanwei Plaza No.7 Guanghua Road, Chaoyang District Beijing People’s Republic of China Dear Sir or Madam: We hereby consent to the references to us by IFM Investments Limited (“the Company”) under the heading “Risks Related to Doing Business in China” in the Annual Report on] [Consent of Independent Registered Public Accounting Firm We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-169542) of IFM Investments Limited of our report dated May 24, 2011 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. Beijing, the People’s Republic]

Skip to toolbar